Edwards Lifesciences reported $448M in EBITDA for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US USD 2.13B 454M
Atricure ATRC:US USD -7736000 2.99M
Baxter International BAX:US USD 855M 68M
Becton, Dickinson and BDX:US USD 1.24B 11M
Boston Scientific BSX:US USD 860M 58M
Cardiovascular Systems CSII:US USD -9682000 1.4M
Cooper Companies COO:US USD 201.7M 20.6M
Cryolife CRY:US USD 2.28M 4.78M
Dexcom DXCM:US USD 186.7M 66.1M
Edwards Lifesciences EW:US USD 448M 55.8M
Globus Medical GMED:US USD 76.63M 6.97M
Hologic HOLX:US USD 349.4M 64.4M
Icu Medical ICUI:US USD 72.67M 7.47M
Insulet PODD:US USD 18.8M 1000K
Integra Lifesciences IART:US USD 105.31M 2.5M
Intuitive Surgical ISRG:US USD 400.9M 95.8M
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Masimo MASI:US USD 79.2M 28.9M
Medtronic MDT:US USD 2.38B 381M
Merit Medical Systems MMSI:US USD 39.07M 15.11M
Nuvasive NUVA:US USD 61.5M 436K
Stryker SYK:US USD 1.48B 389M
Tandem Diabetes Care TNDM:US USD -43985000 35.3M
Teleflex TFX:US USD 182.91M 8.88M
Zimmer Biomet Holdings Inc ZBH:US USD 610.5M 85.6M